Logo image of DNUT

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

NASDAQ:DNUT - Nasdaq - US50101L1061 - Common Stock - Currency: USD

4.32  -0.02 (-0.46%)

After market: 4.37 +0.05 (+1.16%)

Fundamental Rating

2

Overall DNUT gets a fundamental rating of 2 out of 10. We evaluated DNUT against 136 industry peers in the Hotels, Restaurants & Leisure industry. DNUT has a bad profitability rating. Also its financial health evaluation is rather negative. DNUT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year DNUT was profitable.
DNUT had a positive operating cash flow in the past year.
DNUT had negative earnings in 4 of the past 5 years.
Each year in the past 5 years DNUT had a positive operating cash flow.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

DNUT's Return On Assets of 0.10% is on the low side compared to the rest of the industry. DNUT is outperformed by 62.50% of its industry peers.
DNUT has a Return On Equity of 0.27%. This is comparable to the rest of the industry: DNUT outperforms 52.21% of its industry peers.
Industry RankSector Rank
ROA 0.1%
ROE 0.27%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

DNUT has a Profit Margin of 0.19%. This is in the lower half of the industry: DNUT underperforms 62.50% of its industry peers.
DNUT has a worse Gross Margin (32.34%) than 73.53% of its industry peers.
DNUT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.19%
GM 32.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DNUT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DNUT has more shares outstanding
DNUT has a worse debt/assets ratio than last year.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 0.50, we must say that DNUT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.50, DNUT is doing worse than 77.94% of the companies in the same industry.
A Debt/Equity ratio of 0.74 indicates that DNUT is somewhat dependend on debt financing.
The Debt to Equity ratio of DNUT (0.74) is better than 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF N/A
Altman-Z 0.5
ROIC/WACCN/A
WACC8.04%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

DNUT has a Current Ratio of 0.36. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.36, DNUT is doing worse than 83.09% of the companies in the same industry.
DNUT has a Quick Ratio of 0.36. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DNUT (0.30) is worse than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.3
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.14%.
The Revenue has decreased by -1.23% in the past year.
Measured over the past years, DNUT shows a quite strong growth in Revenue. The Revenue has been growing by 11.66% on average per year.
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.89%
Revenue 1Y (TTM)-1.23%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-10.4%

3.2 Future

DNUT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 51.74% yearly.
Based on estimates for the next years, DNUT will show a small growth in Revenue. The Revenue will grow by 1.35% on average per year.
EPS Next Y-25.29%
EPS Next 2Y44.9%
EPS Next 3Y51.74%
EPS Next 5YN/A
Revenue Next Year-2.69%
Revenue Next 2Y4.35%
Revenue Next 3Y1.35%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.00, DNUT can be considered very expensive at the moment.
DNUT's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.33, DNUT is valued a bit more expensive.
DNUT is valuated quite expensively with a Price/Forward Earnings ratio of 48.19.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DNUT is on the same level as its industry peers.
DNUT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.37.
Industry RankSector Rank
PE 36
Fwd PE 48.19
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

DNUT's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.31
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5

4.3 Compensation for Growth

DNUT's earnings are expected to grow with 51.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.9%
EPS Next 3Y51.74%

More info and screens

4

5. Dividend

5.1 Amount

DNUT has a Yearly Dividend Yield of 3.37%.
The stock price of DNUT dropped by -51.68% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
DNUT's Dividend Yield is rather good when compared to the industry average which is at 3.92. DNUT pays more dividend than 86.76% of the companies in the same industry.
DNUT's Dividend Yield is a higher than the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 3.37%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.
DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

765.49% of the earnings are spent on dividend by DNUT. This is not a sustainable payout ratio.
DP765.49%
EPS Next 2Y44.9%
EPS Next 3Y51.74%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
DNUT Dividend Payout.DNUT Dividend Payout, showing the Payout Ratio.DNUT Dividend Payout.PayoutRetained Earnings

More info and screens

KRISPY KREME INC

NASDAQ:DNUT (4/22/2025, 7:14:23 PM)

After market: 4.37 +0.05 (+1.16%)

4.32

-0.02 (-0.46%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners62.51%
Inst Owner Change0.3%
Ins Owners3.86%
Ins Owner Change0.9%
Market Cap735.70M
Analysts76.25
Price Target12.05 (178.94%)
Short Float %28.09%
Short Ratio7.44
Dividend
Industry RankSector Rank
Dividend Yield 3.37%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP765.49%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-23 2025-04-23 (0.035)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-141.05%
Min EPS beat(2)-192.23%
Max EPS beat(2)-89.88%
EPS beat(4)1
Avg EPS beat(4)-69.11%
Min EPS beat(4)-192.23%
Max EPS beat(4)7.96%
EPS beat(8)3
Avg EPS beat(8)-41.27%
EPS beat(12)5
Avg EPS beat(12)-29.89%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.37%
Min Revenue beat(2)-4.66%
Max Revenue beat(2)-2.08%
Revenue beat(4)0
Avg Revenue beat(4)-1.99%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-0.02%
Revenue beat(8)2
Avg Revenue beat(8)-1.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.13%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.78%
PT rev (3m)-21.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-194.62%
EPS NY rev (1m)-70.76%
EPS NY rev (3m)-71.59%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-8.78%
Revenue NY rev (1m)-1.42%
Revenue NY rev (3m)-8.38%
Valuation
Industry RankSector Rank
PE 36
Fwd PE 48.19
P/S 0.44
P/FCF N/A
P/OCF 16.05
P/B 0.65
P/tB N/A
EV/EBITDA 13.31
EPS(TTM)0.12
EY2.78%
EPS(NY)0.09
Fwd EY2.08%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.27
OCFY6.23%
SpS9.78
BVpS6.66
TBVpS-4.3
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.1%
ROE 0.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.19%
GM 32.34%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF N/A
Debt/EBITDA 6.98
Cap/Depr 90.42%
Cap/Sales 7.25%
Interest Coverage N/A
Cash Conversion 37.88%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.3
Altman-Z 0.5
F-Score7
WACC8.04%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.89%
EPS Next Y-25.29%
EPS Next 2Y44.9%
EPS Next 3Y51.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.23%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-10.4%
Revenue Next Year-2.69%
Revenue Next 2Y4.35%
Revenue Next 3Y1.35%
Revenue Next 5YN/A
EBIT growth 1Y-423.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year753.48%
EBIT Next 3Y128.41%
EBIT Next 5YN/A
FCF growth 1Y1.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.63%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%